What does this research mean for the field?

Thyroglobulin autoantibodies do not influence overall or disease-free survival outcomes in patients with differentiated thyroid carcinoma. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess whether the presence of thyroglobulin autoantibodies influences survival outcomes in patients with differentiated thyroid carcinoma.

March 14, 2026Open Access

View Full Paper

Thyroglobulin Autoantibodies Do Not Influence the Outcome of Patients With Differentiated Thyroid Carcinoma

CBC. BornemannUniversitätsmedizin Göttingen CBCaroline BouterUniversitätsmedizin Göttingen

Key Points

To assess whether the presence of thyroglobulin autoantibodies influences survival outcomes in patients with differentiated thyroid carcinoma.
Analysis of patient outcomes based on thyroglobulin autoantibody status
Assessment of overall and disease-free survival rates
Longitudinal follow-up of monitored patients with positive TgAb
No significant influence of TgAb on overall survival reported
No significant influence of TgAb on disease-free survival noted
Recommendations for careful monitoring and avoidance of overtreatment provided

Abstract

The presence of TgAb did not influence the outcome regarding overall and disease-free survival. Results implicate that the initial appearance of TgAb does not influence the outcome of patients with DTC. Patients with positive TgAb should be monitored closely during follow-up as Tg measurement is unreliable, while overtreatment should be avoided.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Bornemann et al. (Sun,) studied this question.

synapsesocial.com/papers/69b4fc59b39f7826a300d187 https://doi.org/https://doi.org/10.1002/edm2.70198

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper